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Abstract: MR-Guided Cardiac Interventions
Diagnostic and interventional cardiac catheterisation is routinely used in the diagnosis
and treatment of congenital heart disease. There are well-established concerns
regarding the risk of radiation exposure to patients and staff, particularly in children
given the cumulative effects of repeat exposure. MRI offers the advantage of being
able to provide better soft tissue visualisation, tissue characterisation and quantification
of ventricular volumes and vascular flow. Initial work using MRI catheterisation
employed fusion of X-ray and MRI techniques, with X-ray fluoroscopy to guide catheter
placement and subsequent MRI assessment for anatomical and haemodynamic
assessment. Image overlay of 3D previously acquired MRI datasets with live
fluoroscopic imaging has also been used to guide catheter procedures.
Hybrid X-ray and MRI guided catheterisation paved the way for clinical application and
validation of this technique in the assessment of pulmonary vascular resistance and
pharmacological stress studies. Purely MRI guided catheterisation also proved
possible with passive catheter tracking. First-in-man MRI guided cardiac catheter
interventions were possible due to the development of MRI compatible guide-wires, but
halted due to guidewire limitations.
More recent developments in passive and active catheter tracking have led to
improved visualisation of catheters for MRI guided catheterisation. Improvements in
hardware and software have also increased image quality and scanning times with
better interactive tools for the operator in the MRI catheter suite to navigate through the
anatomy as required in real-time. This has expanded to MRI guided electrophysiology
studies and radiofrequency ablation in humans. Animal studies show promise for the
utility of MRI guided interventional catheterisation. Ongoing investment and
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development of MRI compatible guide-wires have will pave the way for MRI guided
diagnostic and interventional catheterisation coming into the mainstream.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
Title: MR-Guided Cardiac Interventions 
Authors: 
Kuberan Pushparajah MD1,2 
Henry Chubb MBBS, MA1,2  
Reza Razavi MD1,2 
1. Division of Imaging Sciences and Biomedical Engineering, King's College London 
2. Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust 
 
Corresponding author: 
Reza Razavi 
Division of Imaging Sciences and Biomedical Engineering,  
King's College London, 
Rayne Institute, 4th Floor Lambeth Wing, 
St Thomas's Hospital, 
Westminster Bridge Road, 
London SE1 7EH, The United Kingdom 
Email: reza.razavi@kcl.ac.uk 
 
 
 
 
 
 
Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends)
Introduction 
Cardiac catheterisation is conventionally guided by fluoroscopy with the inherent concerns of 
radiation exposure to staff 1-5 and patients. The risk of developing a solid tumour as a result of a 
single cardiac catheterisation procedure is approximately 1 in 2500 in adults, and 1 in 1000 in 
children if exposure occurs at 5 years of age6-9. The proportion of the body that is irradiated 
increases as the size of the patient decreases, and some procedures require much longer X-ray 
exposure and repeat interventions.   
 
The last three decades have seen significant advances in cardiovascular magnetic resonance 
(CMR), and these advances have supported research into interventional applications using CMR10-
13.  The need for an imaging modality that offers superior structural delineation of complex cardiac 
anatomy, multiplanar imaging and additional physiologic information, without the risk of ionizing 
radiation, has allowed CMR guidance of cardiac catheterisation procedures to become a reality. 
Clinical programs using CMR-guided cardiac catheterization have since developed with promising 
results.14-17. 
 
Advantages of CMR 
Improved visualization of cardiac anatomy 
X-ray-guided cardiac catheterization has poor contrast of soft tissues, such as the heart and great 
vessels. A skilled operator has to rely on recognizing anatomic structures from previous experience 
or on contrast angiographic images acquired earlier in the procedure. The lack of adequate 
visualization increases the risk of perforating the heart or great vessels, especially in complex 
interventional procedures. Cardiac interventions can involve selection of an appropriate device and 
its successful deployment within the heart or great vessels, which requires accurate measurement 
of the size of defects and nearby anatomic structures. Such measurements can be difficult with X-
Ray fluoroscopy (XRF). CMR provides excellent soft tissue visualisation of the cardiac chambers 
and vessels in 3D whole heart images as well as 2D slices in any plane. Tissue characterisation by 
CMR also allows targeting a region of interest such as myocardial biopsy in areas of scar 18.  
 
Physiologic information 
Conventional cardiac catheterization is also used to obtain functional information. Invasive 
pressures and blood gases are commonly used to calculate systemic and pulmonary blood flow 
and resistance.  The Fick principle is used to estimate flow, and is dependent on multiple 
measurements (haemoglobin, aortic/pulmonary artery oxygen saturation, partial pressure, oxygen 
consumption), which can be a considerable source of inaccuracy. Accuracy is further reduced in 
patients with large intracardiac shunts and high pulmonary blood flow19-24.  
 
Velocity encoded phase contrast CMR is a validated technique that enables non-invasive 
quantification of blood flow in major vessels. Cardiac output and the pulmonary-to-systemic flow 
ratio (Qp:Qs) measured using this technique have been shown to be accurate25-31. This set the path 
for a novel method of quantification of pulmonary vascular resistance (PVR) in patients with 
congenital heart disease and or pulmonary hypertension by combining invasive pressure 
measurements and CMR flow data32-34. PVR assessment in this way has been utilised in large 
clinical case series with good results and is an accepted part of routine clinical practice where it is 
viewed as a 'gold-standard' 17,35. 
 
Assessment of global and regional ventricular function can also be carried more accurately with 
cine steady-state free precession (SSFP) cardiovascular MR than with X-ray angiography. 
Cardiovascular MR does not rely on assumptions about cardiac geometry, unlike with XRF or 
even echocardiography, which is particularly relevant in CHD.  
 
Combining invasive pressure measurements with CMR-derived blood flow and ventricular 
volumes opens up interesting new ways of investigating pathophysiology. It allows for the study 
of pulmonary vascular compliance, derived ventricular pressure-volume loops, and assessment of 
load-independent ventricular function36-39. Pharmacological stress studies have also been applied 
in CMR/XMR catheter studies to assess haemodynamic responses39-44. 
 
Using CMR for electrophysiological procedures 
CMR-guidance of electrophysiological (EP) procedures presents three fundamental advantages. 
The first is that of identification and improved targeting of the arrhythmia substrate: CMR has 
been demonstrated to be capable of delineating the regions of tissue damage and fibrosis that are 
integral in the instigation and perpetuation of arrhythmias 45,46. The second is the optimization of 
intra-procedural guidance with the use of both passive and active tracking techniques, and the 
imaging of contiguous structures. Finally, the third main advance is the capability for visualization 
and objective assessment of ablation lesions.  
 
EP substrate identification 
Both ventricular and atrial arrhythmogenic substrate have been identified on CMR imaging 47,48, 
and the implementation of data regarding local myocardial characterization is increasingly used to 
guide procedures. Ventricular substrate is generally the more amenable to evaluation by CMR as 
there is increased wall thickness and higher consequent contrast between healthy and pathological 
tissue. Ventricular tachycardia (VT) occurs due to scar related re-entry and scar can be accurately 
visualized using LGE techniques 45,46. In particular, the scar border zone has been shown to be 
critical in the perpetuation of the arrhythmia, and its abolition forms the basis of substrate-based 
VT ablation 49-51. 
 
However, improvements in clinical ablation outcome with the use of CMR-derived substrate 
information have been modest 52. Importantly, though, all studies that have used CMR-derived 
substrate identification to guide ablation have relied upon electroanatomic (EAM) image fusion 
techniques 53-55. For this, the imaging is integrated within the EP procedure by matching the shape 
of the cardiac chambers between the EAM system (derived from tracking all the recorded positions 
of a cardiac catheter within an operator-defined space) and the imaging. Registration errors are 
significant and include discrepancies in landmark identification, cardiac chamber conformational 
changes (arising from differing loading conditions and tachyarrhythmias), and translational 
changes (due to patient movement, cardiac motion and respiratory motion). CMR-derived targets 
may be typically 2-4mm wide for VT ablation 56 and even less for atrial ablation  54,57. Small errors 
in registration mean that either a very broad region must be ablated or critical targets are left 
untouched, with consequent impact on safety, time and efficacy. 
 
EP Lesion imaging 
 
Real-time imaging 
The real-time imaging of ablation lesions, during energy application, has the nearly unique 
potential to enable to titration of energy application to ensure transmural lesions. Steiner et al first 
demonstrated the technical feasibility of real-time in-vivo MR-imaging of RF lesion formation for 
a swine paraspinal muscle ablation 58. However, there is only a small body of literature that has 
demonstrated real-time MR imaging of cardiac lesion formation as clearly it can only be performed 
for MR-guided EP procedures, and relatively few studies have focused upon this aspect of research 
59-61 . The work of the Bordeaux group is particularly promising 61, and implementation within a 
real-time interface appears to be feasible in the near future. 
 
Acute lesion imaging (<4hours) 
There is a great deal more evidence for acute imaging of ablation lesions, but the sensitivity and 
specificity of acute lesion imaging for prediction of chronic lesion formation remains 
controversial. Furthermore, much of the data on human ablation relates to imaging at 24 hours post 
ablation, which is not a clinically useful time interval. Imaging needs to be performed at the same 
procedure in order to guide further ablation, and therefore a maximum time interval of around 4 
hours post-ablation is considered applicable for intra-procedural acute imaging.  
 
In animal models, it has long been established that ventricular lesions can be visualized 
immediately following ablation 62. Detailed delineation of the pharmacokinetics of Gad within 
acute RF injury lesions 63 has been performed, and has been correlated with non-enhanced 
sequences such as T2-weighted, turbo-spin echo techniques 64. First pass hypoenhancement and 
native T1 sequences have been particularly promising, and Vijayakumar et al 65 have demonstrated 
the utility of non-contrast T1w imaging in the acute identification of chronic lesions in a canine 
model of ventricular scar. Non-contrast agent based imaging techniques are particularly attractive 
as they can be repeated multiple times 66. 
 
Clinical studies have also been performed, but accuracy of acute lesion evaluation validation is 
compromised by the absence of a gold standard. Detailed assessment of CMR imaging performed 
at 24 hours, validated by imaging at three months, has corroborated that T2-weighted imaging 
tends to over-estimate chronic scar formation 67. More recently, acute CMR imaging in a paediatric 
VT ablation cohort has shown a correlation with late clinical outcome 68. 
 
CMR fused with X-ray 
CMR can be used in cardiac catheterisation procedures either to directly guide the procedure or 
integrated with X-ray fluoroscopy. Integration with X-ray fluoroscopy can be done in 2 ways. One 
is to fuse the previously acquired 3D CMR image as an image overlay with fluoroscopic images, 
and the other is to use X-ray fluoroscopy to guide cardiac catheterisation, and then obtain 
physiological measurements such as intravascular flows and ventricular stroke volumes and 
function by means of CMR. Fusion of images has been utilised in cardiac catheter laboratories 
using pre-obtained CT, CMR or rotational angiographic images. This has been demonstrated to 
reduce the radiation exposure to the patient by means of pre-planning contrast angiographic 
projections from the 3D datasets, resulting in greater accuracy on the first attempt and fewer 
angiographic runs69. Additionally, it provides a roadmap for guiding cardiac catheter placement in 
complex anatomy without the need for multiples repeat contrast injections. There is an accepted 
registration error of up to 2mm and there are attempts to reduce this further by means of motion 
correction algorithms built into commercial and research systems.  Most commercial systems 
allow image overlay in one fluoroscopic plane, although biplane image overlay systems are being 
developed.   The disadvantage of this approach is that once stiff wires and deployment sheaths are 
passed through the chambers and vessels of the heart, this can distort the anatomy compared to the 
original 3D dataset, resulting in a significant discrepancy in the image overlay (Figure 1). 
Combined X-ray and CMR can also be used in the hybrid CMR suite to define soft tissue changes 
post intervention, for example post stenting of aortic coarctation. 
      
Figure 1 Images from a rotational angiogram overlayed onto x-ray fluoroscopy during 
percutaneous pulmonary valve implantation. In figure 1a, the image overlay appears good. During 
deployment of the valve, the use of a stiff wire distorts the anatomy of the right ventricular outflow 
tract and the previously acquired 3d angiogram is no longer in line with the fluoroscopic image.  
 
Interventional cardiovascular magnetic resonance systems 
 
In the design of an interventional CMR suite, it is important to retain the full capabilities of a state-
of-the-art diagnostic scanner without encumbering the interventionist or creating a risk of high 
radiofrequency (RF). Open-magnet designs allow easier access to the patient, but are only 
available at low field strengths. The cylindrical horizontal bore systems offer higher field strengths 
and gradient slew rates, allowing higher-resolution imaging, shorter scan times, higher signal-to-
noise ratio, reduced image distortion, and improved functionality with real-time imaging, all of 
which are essential for endovascular interventions 70. However, the traditional cylindrical magnet 
design limits access to the patient, especially in small children and babies. Newer magnets with 
shorter bores and flared margins offer better patient access without compromising the advanced 
CMR features of diagnostic scanners.  
 
Despite the inherent potential and promise of CMR-guided interventions and operations, the major 
obstacle is the lack of CMR-compatible catheters and devices. Therefore, the initial work in 
interventional CMR exploited multi-modality imaging, such as X-ray and CMR (XMR) or XMR 
and ultrasound. Such hybrid units already in existence allow the use of separate modalities or a 
combination of them when needed, such as XMR systems, which combine X-ray and CMR by 
having both modalities in the same room, with a tabletop design that allows patients to be moved 
from one modality to the other in less than 1 minute (Figure 2)71-74.  
 
Figure 2 XMR room with the X-ray and MR equipment joined by a movable tabletop. The c-
arm of the X-ray unit is seen in the foreground, ceiling-mounted MR monitor and controls are seen 
in the distance, and the 5-gauss area is demarcated by a change in the floor colouring from the MR 
to the X-ray end of the room. 
 
 
 
Visualisation 
Visualisation requirements include real-time acquisition and near real-time reconstruction, rapid 
sequence changes, interactive control and simultaneous visualization of a catheter or device and 
soft tissue. Improvements in the use of parallel imaging combined with improved processing 
power of computers to support post-processing software, have allowed the development of faster 
strategies for image data acquisition and reconstruction.  This includes novel motion correction 
algorithms which allow for rapid and accurate free breathing acquisitions75,76. It is now possible to 
achieve frame rates of as high as 20 images/sec with the aid of new parallel imaging techniques 
while maintaining suitable spatial resolution for interventional applications77-82. 
 
Crucial to the success of interventional CMR is real-time tracking and visualization of catheters, 
guidewires, and devices in the CMR environment. Device localization under CMR is made 
possible by a variety of approaches that can be broadly classified as either electrically passive or 
electrically active83. 
 Passive Catheter Tracking and Visualization 
The passive tracking technique is commonly based on visualization of susceptibility artefacts or 
signal voids caused by the interventional device under CMR imaging. This is a well-studied 
technique and is clinically feasible84-88 as it does not require any special hardware or software and 
therefore it can be performed on any commercial CMR system. 
 
The ideal passive tracking catheter or guidewire must be made of a material that provides adequate 
physical properties such as torque and steerable and allows tracking without obscuring the 
underlying anatomy. Ferromagnetic materials cause large susceptibility artefacts and therefore are 
not generally suitable for CMR-guided procedures. Alloys, such as nitinol (nickel and titanium), 
have magnetic susceptibility close to that of tissue. Therefore, they are best suited for making 
guidewires and braided catheters but not necessarily CMR safe.  
 
The polymeric materials used for making catheters typically have low magnetic susceptibility and 
therefore cannot be easily localized on CMR images62. Attempts generating susceptibility artefacts 
by locally impregnating the catheter wall with gadolinium-like compounds88 or using gadolinium 
contrast agents in varying concentrations within catheter lumens89 to create either a positive or 
negative signal on CMR imaging90 have had limited success. 
 
Metallic devices and guidewires produce susceptibility artefacts that aid visualization by way of 
the artefacts. Commercial guidewires can heat up during CMR because of standing wave formation 
along the conductive parts longer than a quarter wavelength at the resonant frequency, which 
corresponds to approximately 12 cm in humans at 1.5T91 where wires are inserted to at least that 
length and nearly always much further for cardiac catheterisation. 
 
Guidewires with a fiberglass core and non-metallic guidewires made of resin microparticle 
compound covered by polytetrafluoroethylene have been used for MR-guided interventions in 
animals92,93 and successful clinical trials with interventions in congenital heart disease but these 
have had been difficult to steer and proved to be fragile 94,95. Consequently, a newer nitinol based 
guidewire with iron oxide markers along the length to impart visibility has been developed with 
good preclinical results96.  
 
Balloon angiographic catheters inflated with carbon dioxide, as is done conventionally with X-ray, 
creates a signal void in the CMR image enabling visualization of the tip (Figure 3).  
 
Figure 3 Passive tracking. Inflated balloon angiographic Bermann catheter filled with 0.8 mL 
CO2 from the inferior vena cava to the right pulmonary artery using solely magnetic resonance 
guidance. Arrows show the signal void of the catheter tip as it traverses the inferior vena cava, 
right atrium, tricuspid valve, and right ventricular outflow tract and enters the pulmonary artery. 
 
This method has been used successfully to guide catheters in patients under CMR as form of 
'negative contrast' imaging 14,97. However, the length of the catheter is impossible to visualize 
because the signal void from the catheter length is masked by volume averaging and dephasing 
effects of thicker slices98. A similar approach is to inflate the balloon of the angiographic catheter 
with a 1% concentration of gadolinium contrast agent16 and the balloon appears as a white ball due 
to the signal from the contrast-filled balloon as a form of "positive contrast" imaging.  
 
The success of passive visualization also relies on dedicated scan techniques. A dynamic gradient 
echo sequence, such as SSFP, has been shown to be ideal for passive catheter tracking, especially 
when signal voids or susceptibility artefacts are used for visualization97,99. Cardiac catheterization 
under XRF guidance is usually performed at imaging speeds of 25 to 30 frames/sec. The frame 
rates available for CMR-guided interventions are not comparable because of the post-processing 
of CMR images and their subsequent display, allowing a maximum of 10 to 14 frames routinely. 
Positive contrast visualization is often used by means of using and 'on/off' saturation pulse 
combined with black blood imaging, where the interventional cardiologist visualizes either the soft 
tissue or catheter tip between rapidly changing image frames16.  We have also introduced a partial 
saturation pulse using a real-time single shot acquisition with bssfp readout where each image is 
acquired immediately after a saturation pre-pulse with a reduced saturation angle to achieve partial 
saturation with a temporal resolution of ~7 images per second. The pSAT sequence offers real-
time simultaneous high contrast visualization of the catheter balloon and blood (Figure 4). This 
technique provides excellent passive tracking capabilities during MR-guided catheterization in 
patients100.  
 
Figure 4 PSat sequence guidance of a catheter filled with gadolinium in the inferior vena cava 
of a patient with a cavopulmonary connection. The gadolinium filled tip appears bright white on 
this image. 
 
The use of passive tracking requires significant input from a skilled CMR operator in order to 
manipulate the imaging plane to keep the device within slice. This is relatively easily achieved in 
narrow tubular structures lying within a single plane, such as the aorta, but is much more difficult 
when there is a greater degree of three-dimensional movement as is the case for an EP study or 
ablation within larger cardiac chambers. Thicker imaging slices (>10mm) improve the ability to 
keep the device within plane, but CNR may be impaired to such a degree that the device may not 
be identifiable. There are also two further substantial limitations to passive tracking pertinent to 
MR-guided EP. The first is the difficulty in tracking more than one device at a time: EP frequently 
requires multiple diagnostic and ablation catheters, and the narrow MR imaging planes, in contrast 
to the projection view of fluoroscopy, limits the monitoring of more than one device at a time. The 
second limitation is the requirement to record location relative to cardiac structures. Automated 
image recognition techniques could theoretically be employed when the device tip is in-plane with 
sufficient CNR, enabling device localization to be referenced to pre-defined chambers, but such 
techniques have not been developed for clinical use. 
 
Active Catheter Tracking and Visualization 
The active catheter tracking and visualization method uses an electrical connection to the CMR 
scanner where the device is equipped with a coil or an antenna that functions in either receive-only 
mode or transmit/receive mode. 
 
Active catheters that are used as receivers have a coil or an antenna that receives signal from tissue 
in its immediate vicinity101. These devices rely on the body coil to transmit into the patient. The 
signal received by these coils is used to pinpoint their position. There are two important types of 
active catheters: those based on small coils positioned, for example, at the end of a catheter, and 
those based on a loopless antenna that can run along a catheter or can be made into a guidewire102-
106.  
 
A small resonant coil at the tip of a catheter can be identified by a series of three one-dimensional 
projections along each axis101. This can be done quickly (in three repetition times) and so could be 
repeated for very fast update of the catheter position, allowing real-time tracking of the catheter. 
The position of the catheter could then be projected over a previously acquired road map. Similar 
techniques have been combined with fast/real-time sequences, imaging the heart or vessels using 
surface coils, and the combined (interleaved) sequence has allowed visualization of two 
simultaneously acquired planes as well as visualization of the catheter or device positions in real 
time107-110. Active visualization has great potential because it allows the whole length of the 
catheter or guidewire to be visualized and the imaging plane to be adapted to the moving catheter 
automatically.  These devices use intravascular coils as RF antennas, and the connection to the 
external circuits via a long wire in the strong magnetic field makes induction of an electrical current 
and heating possible.  
 
There are technical challenges regarding RF safety in particular for long transmission lines, which 
must remain capable of conducting V MR-receive signals. An approach based upon miniature 
transformers in the device has been proven to provide both the required tracking robustness and 
RF safety 111,112 and further work has resulted in dedicated EP catheters based on this approach 
113,114. Furthermore, multiple coils can be tracked simultaneously using the same tracking 
sequence, as it is limited only by the number of receivers. 
 
SAFETY  
 
Heating and Electrical Safety of Interventional Equipment 
The potential heating of wires, devices, implants, and other instruments is an important factor in 
CMR development. Intravascular guidewires or device delivery systems with a metal core are 
unsafe in the CMR environment, with documented heating up to 74° C (165° F) of the tip115-118. 
In addition to the bioeffects of CMR and heating and electrical safety of interventional devices, a 
significant risk to interventional procedures is magnetic force and torque exerted by the magnetic 
field on metallic devices119,120.  Interventional devices that are ferromagnetic will be subject to 
both deflection force (translational movement) and torque (rotational movement); therefore, they 
cannot be used for procedures within a CMR scanner. Conventional guidewires made of 
ferromagnetic materials, such as stainless steel, and catheters with metallic braiding, are inherently 
unsafe for use in the CMR environment. However, certain other metallic alloys, such as nitinol are 
CMR compatible and are not affected by the magnetic field in terms of deflection force and torque 
but can still be susceptible to heating and still be unsuitable for use in CMR procedures. 
 
X-RAY AND CARDIOVASCULAR MAGNETIC RESONANCE GUIDANCE 
 
X-Ray and Cardiovascular Magnetic Resonance Facility Design 
The design and clinical practice framework for our XMR facility is outlined in a paper by White 
el al.121. The room design of a typical XMR facility is shown in Figure 2. The XMR suite is 
designed so that half of the room is outside the 5-gauss line of the magnet, permitting the use of 
traditional instruments and devices as well as echocardiography and RF ablation equipment when 
required. A movable tabletop allows patients to be moved easily and quickly between modalities. 
The paramount consideration in the design, construction, and operation of an XMR facility is 
safety, and a comprehensive safety protocol must be drawn up to minimize possible hazards. 
 
Traditionally, CMR scans are planned and conducted from the control room, away from the 
magnet and the patient. However, during CMR-guided cardiac catheterization, there is a need for 
real-time changes to the scanning plane and sequence parameters to follow catheter manipulation 
in the heart and great vessels. Also, the person carrying out the procedure needs to have a clear 
view of the CMR images while performing the cardiac catheter. Therefore, it is useful to have a 
fully functional set of ceiling-mounted, movable screens and scanner controls within the CMR 
scanner room that can be placed at either end of the bore of the scanner, in close proximity to the 
patient.  Some units also have the facility for image overlay with semi-automated whole heart 
segmentation tools122  and these are now commercially available (Interactive Front End, Siemens; 
RTHawk, HeartVista; Cleartrace, MRI Interventions; iSuite, Philips). These platforms have made 
it possible to manipulate through 3 orthogonal planes using an in-room foot pedal to guide live 
cardiac catheterisation in the MRI scanner. 
 
The XMR suite also includes appropriate CMR-compatible anaesthetic equipment and monitoring 
equipment for invasive pressure monitoring via the catheter. All of the anaesthetic and monitoring 
tubing and lines are designed with extra length and are secured to the movable tabletop to ensure 
smooth patient transfer. 
 
 
The electrocardiogram (ECG) and invasive pressure data are sent from the MR-compatible 
monitoring equipment via an optical network to a computer in the control room, where the cardiac 
technician is stationed. The appropriate measurement and recording of the data is made in the usual 
way. The technician has access to monitors that show the appropriate X-ray or CMR images of the 
procedure. The person carrying out the procedure in the room can view the CMR images and any 
monitoring data (e.g., ECG, invasive pressure data) with the addition of commercially available 
MR conditional LCD monitors or projectors available for use in the MRI room for display. Blood 
samples taken during the procedure are labelled in the room and passed to the technician in the 
control room via a wave-guide. 
 
Reliable and accurate ECG synchronization is essential for CMR and in particular CMR-guided 
cardiac catheterization. When catheters are manipulated in the heart, there is the potential to cause 
arrhythmias (tachyarrhythmia or heart block). It is therefore important to perform accurate 
monitoring of the cardiac rhythm at all times during XMR catheterization. Obtaining a reliable 
ECG in the magnet, particularly during some CMR sequences, can be difficult.  Vector 
electrocardiogram (VCG) is a QRS detection algorithm that automatically adjusts to the actual 
electrical axis of the patient's heart and the specific multidimensional QRS waveform. In our 
experience, this greatly improves the reliability of R-wave detection to nearly 100%. A reliable R-
wave, with the P- and T-waves that are also always clearly seen with VCG, allows detection of 
nearly all arrhythmias.  There are now MR-conditional hemodynamic monitoring systems are 
available (Invivo, GE, Medrad) and are sufficient for basic monitoring, but there are still not 
commercial hemodynamic monitoring systems available specifically for use during MR guided 
cardiac catheterisation. 
 
Another challenge of performing cardiac catheterization under CMR guidance is the noise 
generated during scanning. There is a headphone and microphone system in the room that reduces 
the noise, but allows staff to communicate with each other in both the scanner and control rooms. 
There are techniques using infra-red technology to allow full wireless coverage in the scanning 
and control rooms to allow use of multiple headsets (Opto-acoustics, Clear-com, Gaven). 
 
 
Some CMR coils have X-ray-visible components and would need to be removed between CMR 
imaging and X-ray imaging of patients. It is therefore necessary to have specifically designed coils 
that are sufficiently radiotranslucent to be left in place during XRF without deterioration of image 
quality. We use these type of coils in our procedures so that patients do not have to be disturbed 
when moving from one imaging modality to the other123. 
 
 
The XMR suite has positive-pressure air handling and filtration appropriate for a catheterization 
laboratory. There is a scrub room that is also RF and X-ray shielded and can be accessed both from 
the XMR suite and control room.  
 
 
Images of a standard MRI catheterisation in action are displayed in Figure 5. 
 
Figure 5 X-ray and magnetic resonance intervention. 5a. Patient is placed on the magnetic 
resonance tabletop on the X-ray half of the room for sheath insertion.  The MRI coils are 
demonstrated inset. 5b Image artefact from MRI coils on X-ray fluoroscopy. 5c. Patient is slid into 
the MRI scanner for MRI guided catheterisation. 5d. Image of foot pedals for in-room 
manipulation of the imaging planes by the primary operator. 
 
Specific challenges for EP in the MR environment 
The performance of EP procedures in the MR environment presents additional challenges over and 
above those encountered elsewhere. 
 
Electrogram fidelity 
Conventional electrophysiological procedures rely upon the detection of high quality surface and 
intracardiac electrograms, in order to detect accurately timings, changes and abnormalities of 
cardiac activation. However, the MR-environment, particularly time-variable gradient fields and 
magneto-hydrodynamic effects, act to corrupt the low-voltage signals. 
 
Clinically, the surface ECG is currently limited to calculation from four surface adhesive 
electrodes (Expression, Invivo Medical, Gainesville, FL, USA), with marked distortion of many 
components of the ECG. Identification of the ST-segment and P-wave is often obscured, and many 
groups are working on improving the electrogram quality and enabling 12-lead ECG assessment 
124. A 12-lead ECG would be particularly useful for ventricular arrhythmia procedures and is a 
major hurdle to clinical implementation. 
 
There are also challenges related to the detection and transmission of the intra-cardiac electrograms 
(IEGMs). As for a conventional EP laboratory, IEGMs must be high-pass and low-pass filtered, 
often with the addition of further notch filters to account for the frequency of mains electricity and 
other identified sources of noise. Despite filtering however, electrical noise levels remain high in 
the MR-environment and the IEGM voltage must be transmitted via a high resistivity, RF safe, 
transmission line. IEGM fidelity will need to improve significantly in order to enable detection of 
low amplitude signals such as late diastolic potentials 125 but technical solutions are evolving 
rapidly 126. 
 
Anaesthesia and monitoring 
MR-guided EP procedures are currently longer than equivalent procedures using conventional 
guidance, and they are performed in a noisy and potentially claustrophobic environment. 
Therefore, published human studies have been performed under general anaesthesia or deep 
sedation 125-129.  The fundamentals of maintaining and monitoring anaesthesia in the MR-scanner 
room do not differ from those for non-EP procedures, but for longer procedures (up to five hours) 
particular attention is required in stabilizing body temperature and monitoring pressure areas. 
 
A further consideration is the relatively high risk of arrhythmias in this patient group. There is 
currently no commercial MR-conditional defibrillator solution that has been released, although 
there is ongoing work to develop the capabilities 130. Therefore, robust protocols and training must 
be in place for evacuation of the patient to a safe zone for medical resuscitation if required. 
 
Early Experience in Humans 
In our institution we had the first clinical experience of CMR and combined CMR and X-ray 
(XMR) guided cardiac catheterizations14,34,97, which allowed for a significant reduction of overall 
X-ray dose. CMR/XMR catheterizations were initially employed and validated against standard 
cardiac catheterization for the assessment of pulmonary vascular resistance (PVR)14,34. This novel 
MR technique proved to be a more accurate method to quantify PVR in humans; it also offers 
reduced exposure to ionizing radiation15,34. 
 In the past few years the indications have widened to include assessment of anatomy and function, 
cardiac output and hemodynamic measurements during pharmacological stress17,35,37,39,131. We 
have also described an initial clinical experience of CMR guided structural cardiac interventions 
using a CMR compatible guide wire95.  CMR catheterisation has been employed successfully into 
routine clinical practice at several centres with experience of over 100 cases 16. At our own unit, 
we have performed over 214 MRI catheterisations in the first 10 years of the programme17 in a 
range of patient weights from 2.3kg to 108kg with a good safety profile. This includes the CMR 
guided interventions in man as described below. The majority of the assessments were for PVR 
evaluation.  We found that PVR assessments in this way were a safe and accurate tool, which 
allowed for risk stratification of patients with congenital heart disease being considered for 
intervention 35.  
 
Pharmacological stress studies with dobutamine are employed to increase the heart rate and 
simulate physiological heart rate responses to exercise to assess the circulation at rest and under 
'stress'.  These studies involved measurements of cardiac output and invasive pressures at baseline 
and are repeated with dobutamine infused at a rate of 10mcg/kg/min for 10 minutes or once a 
stable heart rate or blood pressure rise had been observed and repeated at 20mcg/kg/min. Thus far, 
these are employed in the assessment of patients pre-liver transplant 17,40 and in patients with a 
functionally single ventricle39,41. Our experience that titration in this manner has a very good safety 
profile. Isoprenaline stress studies have been used to assess for latent coarctation43,132.  
 
Interventional Structural/Congenital Cardiac Procedures 
Animal models have shown immense potential of interventional CMR (Figure 6). The 
interventions that were shown to be feasible with passive and active catheter techniques include 
balloon angioplasty of arterial stenoses133-138,stenting of vessels,139-143 and atrial septal 
puncture/septostomy144,145. Device closure of atrial septal defects is another application that has 
been explored146-149. CMR-guided percutaneous pulmonary and aortic valve stent implantation 
have also been performed successfully (Fig. 44-11)140,150. More complex interventions, such as 
percutaneous coronary catheterization and intervention, have also been demonstrated in healthy 
animals using CMR151-154 but limitations in spatial resolution are unlikely to result in coronary 
interventions being a key area for CMR guided interventions.   
 
Figure 6 Schematic of the history of MRI catheterisation in humans and animals. Boxes marked 
in red relate to human studies. Boxes marked white relate to animal studies. 
 
Further animal studies also offer potential interventions in congenital heart disease such as, 
percutaneous VSD closure155 and successful transcatheter creation of bidirectional Glenn shunts 
in pigs 156. The application of interventions has now been extended to humans 95,138. This includes 
balloon dilation of aortic coarctation and pulmonary valvuloplasty in patients under CMR 
guidance alone. In our experience, the youngest patient where this has been achieved was 3.5 
years17,95. 
 
Novel catheters and guidewires have made possible targeted intramyocardial injection of 
progenitor stem cells in myocardial infarction in animal models 109,157-159. Using real-time CMR 
and direct apical access in porcine hearts, prosthetic aortic valves were implanted in the beating 
heart160. This breakthrough application may allow CMR guidance of minimally invasive extra-
anatomic bypass and beating-heart valve repair. MR guidance of intramyocardial gene therapy is 
another exciting field161. The ability of CMR to detect myocardial fibrosis and scar could also open 
up the utility for targeted myocardial biopsy with researchers working on developing appropriate 
biotomes12.  This may well improvement the poor diagnostic yield of myocardial biopsy in the 
evaluation of cardiomyopathy162. 
 
MR-guided EP Procedures 
Research in CMR-guided EP requires a broad team including physicists, engineers, radiologists, 
electrophysiologists and computer scientists. As such, work has been limited to relatively few 
centers worldwide. Pioneering studies by the group in Johns Hopkins established the benchmarks 
for the field in 2000 and highlighted the technical challenges that remained to be overcome 163. 
Progress over the next decade was also made by teams in Boston (USA), Würzberg (Germany) 
and included the implementation of active tracking 59and novel carbon catheters 164.  
 
More recently, centers in London (UK), Utah (USA) and Leipzig (Germany) have advanced the 
field further towards mainstream clinical implementation. Early clinical work using passive 
tracking techniques 128,165 for atrial flutter ablation have advanced to active tracking techniques 
with a workflow resembling that of a conventional EP laboratory 125,126. Over the next few years 
it is anticipated that CMR-guided EP technology (ablation catheters, digital amplifier stimulators, 
MR-conditional defibrillators) will be commercially available and that the technology will advance 
rapidly towards mainstream adoption for specific EP procedures. An example of CMR-guided EP 
platform used during clinical ablation of atrial flutter is given in Figure 7.  
  
Figure 7   CMR-guided EP platform during clinical ablation of atrial flutter using active tracking 
(iSuite, Philips Research, Hamburg). All four panels are demonstrated simultaneously to the 
electrophysiology operator. The two left hand panels show orthogonal reconstructions of a b-SSFP 
3D dataset (multiplanar reconstruction (MPR) 1 and 2). Location of prior ablation lesions are 
shown as red dots. Ablation catheter icon is red, and diagnostic/pacing catheter in green. The upper 
right hand panel is a single frame of a cine acquisition acquired a few seconds before, automatically 
oriented along the shaft of the ablation catheter, demonstrating the ablation catheter position. The 
lower right hand panel shows a close-up of the right atrial shell and the locations of the ablation 
lesions. Colour-coding is according to the timing of atrial activation on mapping whilst pacing 
from the coronary sinus, with earliest activation shown in red. 
 
 
Future perspectives 
There is a move for industry participation in the development of CMR compatible cardiac catheters 
and devices specifically designed for CMR-guided cardiac catheterization.  This is particularly 
relevant in congenital heart disease, where complex anatomy requires wires and end-hole catheters 
with good steerabilty and torque to negotiate the bends of the relevant cardiac and vascular 
structures. Development needs to keep pace with the rigorous processes of regulatory approval 
involved in bringing devices and sequences from a prototype stage to clinical applications.  
 
The cost associated with installing expensive XMR suites, does also limit the widespread 
application of interventional CMR but costs will eventually come down.  Over time, there will 
need to be some verification in terms of the cost-effectiveness of these techniques and its role in 
improving patient outcomes. However, CMR guided catheterisation in children will continue to 
develop as a consequence of the continued strive for better anatomical and physiological data and 
avoidance of radiation.   
 
Alternative approaches to RF safety 
An alternative approach being pursued at the moment is to reduce the potential heating effects of 
radiofrequency (RF) from the scanner to allow use of standard metallic guidewires and catheters 
in the CMR environment. This is particularly relevant in CHD where there it would be 
advantageous to access the wide range of commercially available devices have been specially 
designed to accommodate the range of structural lesions. The application of parallel transmit 
technology allows the potential to improve visualisation of the catheter or wire in its entire length 
without inducing any dangerous heating.  Using an 8-Channel prototype parallel transmit system 
and RF-efficient spiral gradient echo (GRE) imaging we have shown reduced heating of nitinol 
guidewires under CMR to a negligible level. This can then be combined with positive contrast 
imaging to improve visualization of the guidewire in vivo, with promising results, which may lead 
to the use of commercial nitinol guidewires safely and effectively for CMR-guided 
catheterizations. 
 
 
There are now simulation methods of analyzing induced phase artefacts seen in low specific 
absorption rate characterization images, to determine induced current on an interventional device 
166. This induced current distribution can then be used to predict RF heating behaviour under 
application of any other imaging sequence without the need to induce potentially damaging heating 
in patients during testing.  
 
Conclusion 
CMR is already in use for diagnostic catheterization with proof of concept seen for interventional 
MRI and EP. There are significant advancements in scanning protocols, segmentation and 
visualization/interaction tools which are making significant inroads on the historical barriers to 
progress due to issues related to hardware and software.  
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FIGURE LEGENDS 
Figure 1: Images from a rotational angiogram overlayed onto X-ray fluoroscopy during 
percutaneous pulmonary valve implantation. In figure 1a, the image overlay appears good. During 
deployment of the valve, the use of a stiff wire distorts the anatomy of the right ventricular outflow 
tract and the previously acquired 3D angiogram is no longer in line with the fluoroscopic image.  
 
Figure 2 XMR room with the X-ray and MR equipment joined by a movable tabletop. The c-
arm of the X-ray unit is seen in the foreground, ceiling-mounted MR monitor and controls are seen 
in the distance, and the 5-gauss area is demarcated by a change in the floor colouring from the MR 
to the X-ray end of the room. 
 
Figure 3 Passive tracking. Inflated balloon angiographic Bermann catheter filled with 0.8 mL 
CO2 from the inferior vena cava to the right pulmonary artery using solely magnetic resonance 
guidance. Arrows show the signal void of the catheter tip as it traverses the inferior vena cava, 
right atrium, tricuspid valve, and right ventricular outflow tract and enters the pulmonary artery. 
 
Figure 4 PSat sequence guidance of a catheter filled with gadolinium in the inferior vena cava 
of a patient with a cavopulmonary connection. The gadolinium filled tip appears bright white on 
this image. 
 
Figure 5 X-ray and magnetic resonance intervention. 5a. Patient is placed on the magnetic 
resonance tabletop on the X-ray half of the room for sheath insertion.  The MRI coils are 
demonstrated inset. 5b Image artefact from MRI coils on X-ray fluoroscopy. 5c. Patient is slid into 
the MRI scanner for MRI guided catheterisation. 5d. Image of foot pedals for in-room 
manipulation of the imaging planes by the primary operator. 
 
Figure 6   Schematic of the history of MRI catheterisation in humans and animals. Boxes marked 
in red relate to human studies. Boxes marked white relate to animal studies.  
 
 
Figure 7   CMR-guided EP platform during clinical ablation of atrial flutter using active tracking 
(iSuite, Philips Research, Hamburg). All four panels are demonstrated simultaneously to the 
electrophysiology operator. The two left hand panels show orthogonal reconstructions of a b-SSFP 
3D dataset (multiplanar reconstruction (MPR) 1 and 2). Location of prior ablation lesions are 
shown as red dots. Ablation catheter icon is red, and diagnostic/pacing catheter in green. The upper 
right hand panel is a single frame of a cine acquisition acquired a few seconds before, automatically 
oriented along the shaft of the ablation catheter, demonstrating the ablation catheter position. The 
lower right hand panel shows a close-up of the right atrial shell and the locations of the ablation 
lesions. Colour-coding is according to the timing of atrial activation on mapping whilst pacing 
from the coronary sinus, with earliest activation shown in red. 
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 1a.tif
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 1b.tif
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 2.tif
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 3.tif
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 4.tif
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 5a.tif
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 5b.tif
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 5c.tif
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 5d.tif
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 6.tif
Manuscript (All Manuscript Text Pages, including Title Page, References and Figure
Legends)
Click here to download Manuscript (All Manuscript Text Pages, including Title Page,
References and Figure Legends) Figure 7.tif
